Department of Obstetrics and Gynecology, Yale University, New Haven, Connecticut.
Department of Obstetrics and Gynecology, Staten Island University, Staten Island, New York.
Am J Perinatol. 2024 May;41(S 01):e2403-e2409. doi: 10.1055/a-2113-2892. Epub 2023 Jun 20.
This study aims to determine if pregnant patients with both pyelonephritis and anemia are at an increased risk of adverse maternal outcomes compared with those with pyelonephritis without anemia.
We conducted a retrospective cohort study utilizing the Nationwide Readmissions Database (NRD). Patients with antepartum pyelonephritis-associated hospitalizations from October 2015 to December 2018 were included. International Classification of Diseases codes were used to identify pyelonephritis, anemia, maternal comorbidities, and severe maternal morbidities. The primary outcome was a composite of severe maternal morbidity, as defined by the Centers for Disease Control criteria. Univariate statistical methods, weighted to account for complex survey methods in the NRD, were used to assess for associations between anemia, baseline characteristics, and patient outcomes. Weighted logistic and Poisson regressions were used to assess for associations between anemia and outcomes, adjusting for clinical comorbidities and other confounding factors.
In total, 29,296 pyelonephritis admissions were identified, corresponding to a weighted national estimate of 55,135 admissions. Of these, 11,798 (21.3%) were anemic. The rate of severe maternal morbidity was higher among anemic patients than nonanemic patients (27.8 vs. 8.9%, respectively, < 0.001), and remained higher after adjustment (adjusted relative risk [aRR] 2.86 [95% confidence interval [CI]: 2.67, 3.06]). Rates of individual components of severe maternal morbidities, including acute respiratory distress syndrome (4.0 vs. 0.6%, aRR 3.97 [95% CI: 3.10, 5.08]), sepsis (22.5 vs. 7.9%, aRR 2.64 [95% CI: 2.45, 2.85]), shock (4.5 vs. 0.6%, aRR 5.48 [95% CI: 4.32, 6.95]), and acute renal failure (2.9 vs. 0.8%, aRR 1.99 [95% CI: 1.55, 2.55]) were all higher for anemic pyelonephritis. The mean length of stay was also longer (25% average increase, 95% CI: 22, 28%).
Among pregnant patients with pyelonephritis, those with anemia are at greater risk of severe maternal morbidity and longer hospital stay.
· Anemia is associated with longer stays for pyelo.. · Anemic pyelo patients have increased morbidity.. · Anemic pyelo patients have increased sepsis risk..
本研究旨在确定患有肾盂肾炎和贫血的孕妇与单纯患有肾盂肾炎而无贫血的孕妇相比,其不良母婴结局的风险是否增加。
我们进行了一项回顾性队列研究,利用了全国再入院数据库(NRD)。纳入了 2015 年 10 月至 2018 年 12 月因产前肾盂肾炎相关住院的患者。国际疾病分类代码用于识别肾盂肾炎、贫血、母体合并症和严重的母体并发症。主要结局是由疾病控制中心标准定义的严重母体发病率的综合指标。使用单变量统计方法,加权考虑 NRD 中的复杂调查方法,评估贫血、基线特征和患者结局之间的关联。使用加权逻辑回归和泊松回归评估贫血与结局之间的关联,同时调整临床合并症和其他混杂因素。
共确定了 29296 例肾盂肾炎入院病例,相当于全国估计有 55135 例入院病例。其中 11798 例(21.3%)为贫血。贫血患者的严重母体发病率高于非贫血患者(分别为 27.8%和 8.9%,均<0.001),调整后仍较高(调整后的相对风险[ARR] 2.86[95%置信区间[CI]:2.67,3.06])。严重母体发病率的各个组成部分的发生率,包括急性呼吸窘迫综合征(4.0%对 0.6%,ARR 3.97[95%CI:3.10,5.08])、败血症(22.5%对 7.9%,ARR 2.64[95%CI:2.45,2.85])、休克(4.5%对 0.6%,ARR 5.48[95%CI:4.32,6.95])和急性肾功能衰竭(2.9%对 0.8%,ARR 1.99[95%CI:1.55,2.55])在贫血性肾盂肾炎患者中均更高。平均住院时间也更长(95%CI:22,28%,平均增加 25%)。
在患有肾盂肾炎的孕妇中,贫血者发生严重母体发病率和住院时间延长的风险更高。